Most Popular

Italy: OMX Groupe enters Italian market with acquisition of Next Medical

France-based OMX Groupe, a medical technology distribution group. has completed the acquisition of Next Medical, an Italy-based distributor of medical devices in the fields of orthopaedics, traumatology and plastic surgery.  This transaction marks OMX's entry into the Italian market and strengthens its European network. Founded in 2010 by Tommaso Cherubino, Next...

Europe’s opportunity to capture the value in China biotech. McDermott Will & Schulte’s Emmanuelle Trombe and Anthony Paronneau talk to Investors in Healthcare

China is no longer simply a low-cost engine for biotech development but an increasingly important source of innovation. For European companies and investors, that creates an opportunity to participate in the next stage of Chinese biotech's globalisation. The challenge is working out how to capture the value. A recent roundtable on China's biotech ecosystem held by global law firm McDermott Will & Schulte, which brought together voices from across the biotech and investment landscape, highlighted the growing sophistication of the country's pharmaceutical sector and the opportunities for international partnerships. The discussion...